Crispr Therapeutics shares owned by TFC Financial Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by TFC Financial Management
from 13F filings
Historical chart of TFC Financial Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by TFC Financial Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by TFC Financial Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $48k | 700 | 68.16 |
| 2023-12-31 | $44k | 700 | 62.60 |
| 2023-09-30 | $908 | 20 | 45.40 |
| 2023-06-30 | $1.1k | 20 | 56.15 |
| 2023-03-31 | $905 | 20 | 45.25 |
| 2022-12-31 | $813 | 20 | 40.65 |
| 2022-09-30 | $1.0k | 20 | 50.00 |
| 2022-06-30 | $1.0k | 20 | 50.00 |
| 2022-03-31 | $1.0k | 20 | 50.00 |
| 2021-12-31 | $22k | 289 | 76.12 |
| 2021-09-30 | $32k | 289 | 110.73 |
| 2021-06-30 | $47k | 289 | 162.63 |
| 2021-03-31 | $35k | 289 | 121.11 |
| 2020-12-31 | $44k | 289 | 152.25 |
| 2020-09-30 | $22k | 269 | 81.78 |